Invention Grant
- Patent Title: Method of inhibiting C5 cleavage
-
Application No.: US14624909Application Date: 2015-02-18
-
Publication No.: US09834585B2Publication Date: 2017-12-05
- Inventor: Miles Andrew Nunn
- Applicant: VOLUTION IMMUNO PHARMACEUTICALS SA
- Applicant Address: CH Geneva
- Assignee: Volution Immuni Pharmaceuticals SA
- Current Assignee: Volution Immuni Pharmaceuticals SA
- Current Assignee Address: CH Geneva
- Agency: McNeill Baur PLLC
- Priority: GB0312619.0 20030602; GB0327386.9 20031125
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/435
Abstract:
The invention relates to complement inhibitors that inhibit both the classical and alternative complement pathways. In particular, the invention relates to complement inhibitors derived from the salivary glands of haematophagous arthropods that inhibit both the classical and alternative complement pathways. The invention also relates to the use of the complement inhibitors in the treatment and prevention of diseases.
Public/Granted literature
- US20160096870A1 COMPLEMENT INHIBITORS Public/Granted day:2016-04-07
Information query
IPC分类:
